SP² Therapeutics
Cutting-edge peptide chemistry research from South Korea
As a spinoff from Seoul National University, our team at SP² Therapeutics boasts global expertise spanning resin-based chemistry, bioinformatics, engineering, and more.
Redefining Peptide Synthesis
We use bioinformatics, AI, and chemical synthesis to develop our patent-pending FLOWSMART system, combining SPPS peptide chemistry with AI-guided, resin-based flow chemistry, achieving massive cost savings and scalability.
Existing production methods cannot meet the current demand for peptide drugs
Certain dosages of peptide drugs, such as Eli Lilly & Co.’s Mounjaro, are facing a significant shortage because of unprecedented patient demand. This has resulted in sporadic backorders, as reported by the US Food and Drug Administration.
FLOWSMART
Advantages of the FLOWSMART system
Rapid Turnaround
Experience peptide synthesis that’s 20 times quicker than existing methods—key for accelerated drug trials.
Cost and Scale Efficiency
The FLOWSMART system slashes synthesis expenses by more than 10 times, and is adaptable from lab bench to industrial production.
Accessible Entry
Thanks to a 15 times initial cost reduction, FLOWSMART clears the path for next-gen drug synthesis pioneers.
Combating the obesity epidemic
We’re reshaping obesity treatment with an innovative oral peptide therapeutic pipeline. Inspired by leading obesity treatments, our team is exploring molecular targets for appetite control, energy optimization, and metabolism. Our goal is to create effective, safe, and accessible solutions.
Peptide
Nucleic Acids
Our advanced technology stands poised to unlock transformative solutions in genetic medicine, offering potential cures and treatments that are both innovative and effective.
High-Performance
Cosmetics
We’re embarking on a journey to craft superior cosmetic products for skincare. Our aim is to blend scientific rigor with cosmetic artistry, creating formulations that not only rejuvenate and protect the skin but also set new standards in beauty solutions.
Company
SP² Therapeutics Inc.
Contact
Institute of Molecular Biology & Genetics, Bldg 105, Rm 312, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul, Korea 151-742